Search
for
Sort by
Research 481–510 of 540
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
- Clinical Characteristics of Hyperandrogenism Include Hirsutism, Polycystic Ovary Syndrome, and Acne: Association with Psychiatric Disease in Women -A Nationwide Population-Based Cohort Study in Taiwan
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- The Economic Burden of Alopecia Areata in Romania
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Inflammatory auxo-action in the stem cell division theory of cancer
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Psychiatric morbidity in children and adolescents with dermatological disorders
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Case Report: Successful Use of Minoxidil to Promote Facial Hair Growth in an Adolescent Transgender Male
- Psycho-emotional conditions of patients with non-cicatrazing alopecia (circumsribed, androgenetic)
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Comparison of Quantitative Evaluation and Conventional Scar Scale Analysis for Pediatric Pathological Scars
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- SRD5A2 and emerging therapies in androgen-driven disorders
- Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Finasteride Use Does Not Lead to Depression or Suicide: Insights From a Large‐Scale Cohort Study and Mendelian Randomization Analysis
- The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results
- Association between androgenetic alopecia and psychological well-being: a systematic review and meta-analysis
- Androgenetic alopecia
- The Biomolecular Effects of Finasteride on Male Rat Brain during Administration and after Discontinuation